Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Today, Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic conditions, announced that Fierce Healthcare selected it as a "Fierce 15 ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled ...

Great. Thank you for coming, everybody. I'm James Gordon, Barclays European pharma and biotech analyst. And today, I've got the pleasure of hosting a fireside with GSK. So we're going to hear from GSK ...

Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn Capital ...

Oxygen therapy can help people with COPD breathe better and do daily activities with less difficulty. There are three types of oxygen therapy: compressed oxygen cylinders, liquid oxygen, and oxygen ...

PRIME recognition underscores potential of inhaled RNA therapy to address unmet need in patients with the 3849+10Kb C>T mutationCompany advancing ...

Tarrytown, New York Wednesday, March 4, 2026, 13:00 Hrs [IST] ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chr ...

PHILADELPHIA — Individuals with preexisting cardiovascular disease (CVD) who are admitted to the emergency department for an anaphylactic reaction have significantly poorer outcomes, including a ...

Dupixent growth offsets Eylea declines; pipeline/Libtayo impact post-2026; monitor ROIC & SBC. Click for a REGN update.